TickerFacts.

10x Genomics, Inc. (TXG): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

-$24.79M
Year ended 2025-12-31
-$48.40M
Trailing 12 months to 2026-06-30
2017-12-31: -$14.07M2018-12-31: -$106.86M2019-12-31: -$23.51M2020-12-31: -$520.13M2021-12-31: -$31.14M2022-12-31: -$142.58M2023-12-31: -$229.82M2024-12-31: -$158.68M2025-12-31: -$24.79M-$24.79M
2017-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31-$24.79Mn/m2026-02-13, From 2025-01-01
2024-12-31-$158.68Mn/m2026-02-13, From 2024-01-01
2023-12-31-$229.82Mn/m2026-02-13, From 2023-01-01
2022-12-31-$142.58Mn/m2025-02-13, From 2022-01-01
2021-12-31-$31.14Mn/m2024-02-15, From 2021-01-01
2020-12-31-$520.13Mn/m2023-02-16, From 2020-01-01
2019-12-31-$23.51Mn/m2022-02-18, From 2019-01-01
2018-12-31-$106.86Mn/m2021-02-26, From 2018-01-01
2017-12-31-$14.07Mn/a2020-02-27, From 2017-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Laboratory Analytical Instruments), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
10x Genomics, Inc. (TXG)2025-12-31-$24.79Mn/m
Cytek Biosciences, Inc. (CTKB)2025-12-31-$32.80Mn/m
Bio-Rad Laboratories, Inc. (BIO)2025-12-31$212.60M-49.5%
Revvity, Inc. (RVTY)2025-12-28$761.98M-1.6%
Quanterix Corp (QTRX)2025-12-31-$109.70Mn/m
Bruker Corp (BRKR)2025-12-31$288.50M-34.0%
Illumina, Inc. (ILMN)2025-12-28$1.08Bn/m
Avantor, Inc. (AVTR)2025-12-31$164.00M-89.0%
Agilent Technologies, Inc. (A)2025-10-31$1.77B+1.3%

Compare TXG, CTKB, BIO, RVTY side by side · Screen every company in Laboratory Analytical Instruments ↗